|
Anemia
|
1
|
|
ATP
|
1
|
|
Biomedical Engineering
|
150
|
|
Biopharmaceutical Manufacturing
|
11
|
|
Biopolymer
|
4
|
|
Biotechnology
|
138
|
|
Blood
|
1
|
|
Blood Diseases
|
1
|
|
Bootstrapping
|
1
|
|
Cancer
|
64
|
|
Cancer Drug
|
8
|
|
Cancer Immunotherapy
|
2
|
|
Cancer Research
|
7
|
|
Cancer Therapy
|
35
|
|
Cell Biology
|
11
|
|
Cell Targeting
|
9
|
|
cell therapy
|
6
|
|
Cells
|
10
|
|
Chemistry and Chemical Analysis
|
216
|
|
Chemoattractant
|
1
|
|
Chemotherapy
|
6
|
|
Combination Therapy
|
2
|
|
Computer Aided Drug Design
|
1
|
|
Drug Conjugates
|
9
|
|
Drug Delivery
|
36
|
|
Drug Development
|
71
|
|
Drug Formulation
|
3
|
|
Gene & Cell Therapy
|
4
|
|
Genetics
|
9
|
|
Hematopoietic Stem and Progenitor cells
|
1
|
|
Hematopoietic Stem Cells
|
1
|
|
HTRF
|
1
|
|
Human Pluripotent Stem Cells
|
2
|
|
ICB
|
1
|
|
Immune
|
2
|
|
Immune Cell
|
1
|
|
Immune Checkpoint Blockade
|
2
|
|
Immune Checkpoint Blockage
|
1
|
|
Immunofuctional
|
1
|
|
Immunogenic Cell Death
|
1
|
|
Immunosuppression
|
2
|
|
immunotherapy
|
7
|
|
Influenza
|
3
|
|
Ligand-Targeted Therapeutics
|
6
|
|
Ligands
|
11
|
|
Lymphoma
|
2
|
|
Medicinal Chemistry
|
26
|
|
Molecular Chemistry
|
10
|
|
Nanoparticle
|
3
|
|
Oncology
|
13
|
|
Patient Care
|
18
|
|
PD-1
|
1
|
|
PD-1/PD-L1 Interaction
|
1
|
|
PD-L1
|
1
|
|
Pharmaceutical Analysis
|
12
|
|
Pharmaceutical Development
|
7
|
|
Pharmaceutical Research
|
16
|
|
Pharmaceuticals
|
191
|
|
Pharmacology
|
13
|
|
Polymeric Nanoparticles
|
1
|
|
Regenerative Medicine
|
5
|
|
small molecules
|
8
|
|
solid tumors
|
2
|
|
Sustained Release
|
3
|
|
Therapy
|
4
|
|
Thrombocytopenia
|
1
|
|
Tumor Model
|
2
|
